Hot Investor Mandate: Subsidsiary of China Family Office Backed Corporation Seeks Cross Border Investment Opportunities in Early-Stage Therapeutics, Devices, and In Vitro Diagnostics

27 Nov

A subsidiary of a company that is sponsored by family offices in China is focused on research and distribution of class 2 and 3 medical devices in China, and is one of the major distributors for some of the largest multinational companies. Having offices in both USA and China, the firm has invested in companies that are based in greater Boston area, Los Angeles as well as Canada. The firm has a fund size of $30M, and the typical allocation ranges from $0.5M – $1M, with no specific limit. The firm has invested over 10 companies by now and will continue to expand its portfolio.

The firm is open to therapeutics and medical device companies, but is most interested in in-vitro diagnostic technologies. The firm is looking for companies that are in development or in the pre-clinical stage. The firm mostly invests in seed round but will invest up to pre-A. The firm is also interested in in-licensing opportunities in China as well.

The firm invests globally and does not have specific requirements regarding companies or their management teams.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: